MarketsStocksBALPHARMA
BA

BALPHARMA

NSE: BALPHARMABSE: 524824Healthcare
Download Research Report7-page PDF
85.40
-0.96%
NSE · auto-updates while market open
Prev Close
₹100.45
Day High
₹90.89
Day Low
₹82.71
Mkt Cap
₹138 Cr
P / E
21.9
P / B
1.7
ROE
7.9%
52W High
₹111.18
52W Low
₹60.00
Key Metrics
Market Cap
₹138 Cr
P / E
21.87
P / B
1.68
EV / EBITDA
9.19
ROCE
9.7%
ROE
7.9%
Debt / Equity
1.94
Book Value
₹51.65
EPS
₹3.95
Div Yield
1.4%
Face Value
₹10
Promoter Holding
50.9%
Revenue · ₹ Cr
171
FY20
251
FY21
281
FY22
304
FY23
339
FY24
303
FY25
312
FY26
Net Profit · ₹ Cr
5
6
3
7
7
6
-13
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹3.3
₹3.8
₹1.7
₹4.9
₹4.6
₹4.0
₹-8.6
FY20FY21FY22FY23FY24FY25FY26
P / E Ratio · price ÷ TTM EPS
5325884630-0Jun 21Feb 23Oct 24Jun 26
P/E 21.5×Median 25.0×TTM EPS
Q1 2026 snapshot
Sales
₹84 Cr
Operating profit
-
OPM
-
Net profit
₹4 Cr
EPS
₹2.26
Scorecard · 7 axes
Quality
Weak
31/100
Valuation
Good
21.9×
Growth
Weak
+2.6%
Profitability
Weak
8.8%
Performance
Bad
-13.2%
Entry Point
Good
77%
Red Flags
Avg
1 flag
Shareholding Pattern
50.9%Promoter
Promoter50.9%
FII0.1%
Public49.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue73.1582.9666.5975.1488.0283.84
Net Profit0.525.3750.2090.7171.7913.604
NPM %0.7%6.5%0.3%1.0%2.0%4.3%
AlertPre-trade